Clinical Trial Update: Apixaban for Prevention of Post-angioplasty Thrombosis of Hemodialysis Vascular Access [Phase 4]

View source ↗

Summary

Clinical trial update on apixaban for preventing thrombosis in hemodialysis vascular access (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemodialysis Access Failure

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: National Taiwan University Hospital Hsin-Chu Branch | Conditions: Hemodialysis Access Failure | Phase 4 | Status: UNKNOWN